Sign in
Not yet recruitingNo phase

Eye inflammation flare-ups after a fluocinolone acetonide implant for posterior uveitis

Studies flare-ups in adults with posterior uveitis given fluocinolone acetonide implants.

Key facts

Who runs it
Nantes University Hospital
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant
Status
Not yet recruiting
People taking part
100 people, planned
Started
Jun 2026
Expected to end
Jan 2027
Type of study
Observational
Treatments tested
  • fluocinolone acetonide intravitreal implant
Record updated
24 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with non-infectious uveitis at the back of the eye who were treated with a fluocinolone acetonide intravitreal implant. It looks back at their past medical records.

Age
18 years or older
Sex
All sexes
Disease stage
Non-infectious uveitis (eye inflammation not caused by an infection) affecting the back of the eye. People must also have uveitic macular edema (swelling at the centre of the retina) or inflammation at the back of the eye that does not go away.
Earlier treatment
Must have received a fluocinolone acetonide intravitreal implant (a small implant placed in the eye) before January 2024.

Main reasons for not taking part

  • Uveitis caused by an infection
  • Refusal or documented objection to taking part in the study
  • Follow-up shorter than 12 months after the implant

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adult patients aged 18 years or older
  • Diagnosis of non-infectious uveitis with posterior segment involvement
  • Presence of uveitic macular edema or persistent posterior segment inflammation
  • Treatment with a fluocinolone acetonide intravitreal implant prior to January 2024

Who cannot take part

  • Infectious uveitis
  • Refusal to participate or documented opposition to the study
  • Follow-up duration shorter than 12 months after implantation

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Non-infectious posterior uveitis is a chronic inflammatory eye disease that can lead to irreversible retinal damage and visual impairment due to repeated inflammatory relapses.

Read full original descriptionShow less

The fluocinolone acetonide intravitreal implant is approved for the prevention of inflammatory relapses in this condition, but data from real-world clinical practice remain limited, particularly regarding the intensity of relapses over time.

This multicenter retrospective observational study aims to evaluate the frequency and intensity of inflammatory recurrences in adult patients with non-infectious posterior uveitis treated with a fluocinolone acetonide implant. Clinical and imaging data routinely collected during follow-up will be analyzed over a three-year period to better characterize long-term outcomes, treatment burden, and safety in real-life conditions.

The group in the trial

  • FACi-treated cohort

    Adult patients with non-infectious posterior uveitis or persistent posterior segment inflammation who received a fluocinolone acetonide intravitreal implant as part of routine clinical care.

    Treatment: fluocinolone acetonide intravitreal implant

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Frequency and Intensity of REcurrences in Non-infectious Posterior Uveitis Treated With Fluocinolone Acetonide Implant (FACi): a Multicenter Retrospective Real-world Study
Plain-language title
Eye inflammation flare-ups after a fluocinolone acetonide implant for posterior uveitisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
24 June 2026